Prevest Denpro — 360° view

Prevest Denpro, a company in the Medical Equipment & Supplies industry, reported revenue of ₹22 crore and net profit of ₹6.39 crore for the September 2026 quarter.

Prevest Denpro (BSE: PREVEST) closed at ₹368.20 on 20 Nov 2026, down 20.0% over the past year. Its market capitalisation is ₹442 crore and it trades at 19.6 times earnings.

Share price
₹368.20 (20 Nov 2026)
Market cap
₹442 Cr (20 Nov 2026)
P/E
19.58 (20 Nov 2026)
Revenue
₹22 Cr (September 2026 quarter)
Net profit
₹6 Cr (September 2026 quarter)
ROCE
24.2% (FY26)
ROE
17.8% (FY26)
Book value
₹114 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹514.00 / ₹318.15 (20 Nov 2026)
1-year return
-20.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
BSE: PREVEST

Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.